Stilla Technologies rakes in $22 mn Series B

Stilla Technologies, a French provider of digital PCR solutions for high-precision genetic analysis, has raised $22 million in Series B funding.

11 February 2020•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles